Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) has successfully closed a registered direct offering of 7,040,000 ordinary shares at an offering price of $1.25 per share, raising $8.8 million. The proceeds will fund the completion of Phase 2 clinical trials for na-SPMS and MSA. The offering was led by Tiziana’s CEO and Executive Chairman, who both increased their shareholdings. Foralumab, a fully human anti-CD3 monoclonal antibody, is showing promising results in treating multiple sclerosis. Tiziana Life Sciences is pioneering innovative therapies using transformational drug delivery technologies. The company’s lead candidate, intranasal foralumab, has demonstrated safety and efficacy in clinical studies. 1. The stock market reached new record highs today, with the S&P 500 closing at 4,500 points for the first time ever. This marks a significant milestone in the ongoing recovery from the pandemic-induced economic downturn.

2. A new study published in a leading medical journal found that the Pfizer-BioNTech COVID-19 vaccine is highly effective in preventing severe illness and hospitalization caused by the Delta variant. The study, which analyzed data from over 20,000 patients, showed that the vaccine was 88% effective in preventing hospitalization.

3. In a major breakthrough for renewable energy, a new solar panel technology has been developed that is capable of converting over 40% of sunlight into electricity. This represents a significant improvement over current solar panel efficiency rates, which typically range from 15-20%.

4. The United Nations released a report today highlighting the urgent need for action to address climate change. The report warns that the world is on track to exceed the critical threshold of 1.5 degrees Celsius of global warming within the next decade, with potentially catastrophic consequences for ecosystems and human societies.

Read more at 1. U.S. economy adds 943,000 jobs in July, beating expectations. Unemployment rate drops to 5.4%. – CNBC

2. Apple becomes first $3 trillion company after strong quarterly earnings report. Stock price reaches all-time high. – Wall Street Journal

3. Pfizer-BioNTech COVID-19 vaccine receives full FDA approval for use in individuals 16 and older. – Reuters

4. Amazon announces plans to hire 55,000 employees globally for corporate and tech positions. – CBS MarketWatch

5. Facebook parent company Meta reports a 56% increase in revenue for the second quarter, exceeding analyst expectations. – Barchart: Tiziana Life Sciences Announces Closing of Oversubscribed